Pelthos Therapeutics Inc. PTHS Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue estimate$10.4M
EPS estimate-$0.67
Next report
Aug 12, 2026 (in a month)Revenue estimate$15.2M
EPS estimate-$2.95
Financials
Q3 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Q1 2026-$3.09Beat by $0.36Q4 2025-$2.83Beat by $1.12
Q3 2025-$5.30Miss by $4.63
Q2 2025-$5.38Miss by $2.28Ask the moment Pelthos Therapeutics Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Pelthos Therapeutics Inc. report Q3 2025 earnings?
- Pelthos Therapeutics Inc. (PTHS) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Pelthos Therapeutics Inc.'s Q3 2025 revenue and EPS?
- Pelthos Therapeutics Inc. reported revenue of $7.4M and diluted EPS of $-5.30 for Q3 2025.
- Did Pelthos Therapeutics Inc. beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $10.4M by $3.0M. EPS missed the consensus estimate of $-0.67 by $4.63.
- Where can I find Pelthos Therapeutics Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001753926-25-001766) and the 10-Q periodic report (0001753926-25-001764) directly on SEC EDGAR. The filing index links above go to sec.gov.